Magnetically ‐actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot study

ConclusionsIn conclusion, this study showed for the first time that MADDD, clearly suppressed tumor growth in local prostate cancer tumors. This could potentially be a novel clinical treatment approach for localized prostate cancer.

Source: The Prostate - August 8, 2017 Category: Urology & Nephrology Authors: Werner J. Struss, Zheng Tan, Payam Zachkani, Igor Moskalev, John K. Jackson, Ali Shademani, Ninadh M. D'Costa, Peter A. Raven, Sebastian Frees, Claudia Chavez ‐Munoz, Mu Chiao, Alan I. So Tags: ORIGINAL ARTICLE Source Type: research